Sarepta files Form 13F; 1 holding entry
Sarepta Therapeutics, Inc. filed a Form 13F as an institutional investment manager.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sarepta Therapeutics, Inc. filed a Form 13F as an institutional investment manager. The filing lists 1 Form 13F information table entry and reports a total table value of $0. The report is signed by Ryan Wong, Executive Vice President and Chief Financial Officer, dated 02-12-2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Sarepta Therapeutics report on its Form 13F (SRPT)?
Who signed the Form 13F for Sarepta Therapeutics?
How many other included managers are listed in the Sarepta 13F filing?
Does the filing say the SEC reviewed the information?
What is the filer’s address shown on the Form 13F?
AI-generated analysis. How Rhea-AI works. Not financial advice.